ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985

FDA Policy On Support Of Medical Education Near Final Form

February 5, 1993

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

June 14, 2002

Brain tumor foundations form collaboration.

July 15, 2005

High Radiation Dose Effective Ten Years After Treatment

November 28, 2003

Flexibility OK In Paying Grants If Justified, Upton Affirms

September 1, 1978